<?xml version="1.0" encoding="UTF-8"?>
<p>Prior to myeloablative therapy, all patients at each of the four study sites undergo a complete oral/dental examination by a dentist specialised in orofacial medicine and pathology followed by an odontological decontamination. Meticulous information and instructions for oral hygiene maintenance is also received. Patients who develop OM are initially treated with paracetamol or opioids, depending on degree of symptoms, and further assisted by healthcare professionals to maintain a good oral hygiene. In more severe cases, a dentist or a dental hygienist is contacted for assistance and further support with oral care maintenance.</p>
